![]() |
|
|
Vol. 8, Issue 12, 2365-2378, December 1997

and
*Department of Pharmacology, The University of Texas Southwestern
Medical Center at Dallas, Dallas, Texas 75235-9041; and
Department of Cell Biology and Neuroscience, The
University of Texas Southwestern Medical Center at Dallas, Dallas,
Texas 75235-9039
| |
ABSTRACT |
|---|
|
|
|---|
There is mounting evidence for the organization and
compartmentation of signaling molecules at the plasma membrane. We find that hormone-sensitive adenylyl cyclase activity is enriched in a
subset of regulatory G protein-containing fractions of the plasma membrane. These subfractions resemble, in low buoyant density, structures of the plasma membrane termed caveolae. Immunofluorescence experiments revealed a punctate pattern of G protein
and
subunits, consistent with concentration of these proteins at distinct
sites on the plasma membrane. Partial coincidence of localization of G
protein
subunits with caveolin (a marker for caveolae) was observed
by double immunofluorescence. Results of immunogold electron microscopy
suggest that some G protein is associated with invaginated caveolae,
but most of the protein resides in irregular structures of the plasma
membrane that could not be identified morphologically. Because
regulated adenylyl cyclase activity is present in low-density subfractions of plasma membrane from a cell type (S49 lymphoma) that
does not express caveolin, this protein is not required for organization of the adenylyl cyclase system. The data suggest that
hormone-sensitive adenylyl cyclase systems are localized in a
specialized subdomain of the plasma membrane that may optimize the
efficiency and fidelity of signal transduction.
| |
INTRODUCTION |
|---|
|
|
|---|
Heterotrimeric regulatory G proteins are associated with the inner
face of the plasma membrane, where they are positioned to be activated
by membrane-spanning, heptahelical receptors and to regulate a variety
of intracellular effectors. A common view of the ligand-driven,
protein-protein interactions that characterize G protein-coupled
transmembrane-signaling systems includes random collisions between
proteins that diffuse freely in the plane of the plasma membrane.
However, there is mounting evidence for a higher level of organization
and compartmentation of these signal-transducing molecules. These
suggestions are based on demonstrations of restricted mobilities of
certain receptors and G proteins, the possibility of interactions of
signaling components with the cytoskeleton, and failure to replicate
the high degree of specificity of signaling observed in vivo by
reconstitution of purified proteins in vitro [for review, see Neubig
(1994)
]. Thus, G proteins may be restricted to particular compartments
or specializations of the plasma membrane.
We (Chang et al., 1994
; Smart et al., 1995b
), and
others (Sargiacomo et al., 1993
; Schnitzer et
al., 1995
) have presented evidence that G proteins can be found in
plasma membrane specializations called caveolae. Although these
structures are most often identified morphologically in cross-section
as flask-shaped invaginations of the plasma membrane, they also can
exist in a flattened state. Caveolae can be opened or closed to the
external mileau and play a role in transport processes such as
transcytosis in endothelial cells and potocytosis in epithelial cells.
A growing body of biochemical and morphological evidence also indicates
that a variety of molecules that participate in signal transduction
reactions are concentrated in caveolae [for review see Anderson
(1993)
; Lisanti et al. (1994a)
; and Parton and Simons
(1995)
]. Furthermore, it has been reported by one group of
investigators that G proteins interact directly with caveolin (S.W. Li
et al., 1995
; Scherer et al., 1996
; Tang et
al., 1996
, 1997
), a 21-kDa membrane protein that has been
localized by immunocytochemistry to the membrane coat of caveolae.
However, others (Stan et al., 1996
) have recently questioned
the specificity of subcellular fractionation procedures that have
implied localization of G proteins (and several other molecules) in
caveolae and suggest that this is not their predominant site of
residence, at least in rat lung vasculature.
We have examined the organization of certain G protein subunits in the plasma membrane and, to a lesser extent, the localization of other components of a prototypical G protein-regulated signal transduction pathway, the hormone-sensitive adenylyl cyclase system. Receptors communicate with a pair of homologous G proteins, one of which (Gs) mediates stimulation of adenylyl cyclase, while the other (Gi) is responsible for inhibition. We provide additional evidence that these signaling molecules are localized to distinct domains, a portion of which colocalized with caveolin. Proper organization of these signaling proteins at the plasma membrane may optimize fidelity and efficiency of signal transduction in the intact cell.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
Mammalian cells were cultured in DMEM (high glucose)
supplemented with 10% fetal calf serum, 5 U per ml of penicillin, and 5 µg/ml of streptomycin (unless otherwise noted). Madin Darby canine
kidney (MDCK) cells were transfected with Lipofectamine and either
empty pCB6+ vector (Brewer, 1994
) (clone 1) or the
o expression vector,
opCB6+
(clone 34). Cells were selected, cloned, and maintained in medium containing 500 µg/ml Geneticin (G418 sulfate). MA104 cells were derived from rhesus monkey kidney (Roth et al., 1987
), and
normal human fibroblasts were from skin biopsies. Murine lymphoma (S49) cells were grown suspended in medium supplemented with 10%
heat-inactivated horse serum and no antibiotics. Fall army worm ovarian
(Sf9) cells were propagated by suspension in IPL-41 medium supplemented
with 10% heat-inactivated fetal calf serum as described (Tang et
al., 1991
). All cell culture reagents were purchased from Life
Technologies, Inc. (Gaithersburg, MD) except for IPL-41 medium, which
was from JRH Biosciences (Lenexa, KS).
Antibodies and Western Blotting
Caveolin antibodies (mouse monoclonal and affinity purified
rabbit polyclonal) were purchased from Transduction Laboratories (Lexington, KY). The properties of G protein antibodies are summarized here and in Figure 1. B087 was made (in
rabbit) against a synthetic peptide representing the last 10 amino
acids of
i1 and
i2 (Linder et
al., 1993
); its reactivity by immunoblotting was
i1 =
i2
i3,
o (Figure 1A). A569 was made (in rabbit) against a
"common
" peptide representing amino acids 40-54 of
i (Mumby et al., 1986
); its reactivity by
immunoblotting is
o>
i1 =
i2 =
i3

(Figure 1A).
B600 (Linder et al., 1993
) and T20 (Santa Cruz
Biotechnology, Santa Cruz, CA) were made in rabbit against a peptide
representing the highly homologous carboxyl terminus of
subunit
isoforms. Antiserum 584 is specific for
s (Mumby and
Gilman, 1991
). 2A and R4 are mouse monoclonal antibodies that were
generated against
o or
i1 proteins,
respectively, and each was specific for the immunogen without
cross-reaction with other
subunits when analyzed by western
immunoblotting (X. Li et al., 1995
).
|
For many experiments G protein-specific antibodies were affinity
purified (Mumby et al., 1988
). All antibody preparations employed for immunolocalization were tested for specificity of reactivity by immunoblotting of purified recombinant
subunits (Lee et al., 1994
) and crude membrane fractions
prepared from cultured cells (Mumby et al., 1990
). Samples
were treated with N-ethylmaleimide (50 mM) (Sternweis and
Robishaw, 1984
) and were resolved by SDS-PAGE (Laemmli, 1970
).
Immunoblotting of proteins transferred to
nitrocellulose (Towbin et al., 1979
) was performed with
enhanced chemiluminescence reagents from Amersham (Arlington Heights,
IL).
Immunofluorescence
To obtain plasma membranes, MA104 cells were grown on
poly-L-lysine-coated coverslips. Coverslips were soaked in sterile
poly-L-lysine (0.5 mg/ml) in 0.1 M sodium borate, pH 8, for 30 min or
longer and then rinsed twice with sterile water before cells were
plated. Fibroblasts and MDCK cells required no coating of the
coverslips. Cells on coverslips were sonicated with a Vibra Cell
sonicator (Sonics and Materials, Danbury, CT) set to 40% output/10 J
for MA104 cells and fibroblasts and 80% output/15 J for MDCK cells (Muntz et al., 1992
). Fixation was performed with 4 or 10%
paraformaldehyde with similar results. Coverslips were processed for
immunofluorescence using secondary antibodies (20 µg/ml) labeled with
Oregon Green (Molecular Probes, Eugene, OR) or Texas Red (Zymed, South
San Francisco, CA) (Muntz et al., 1992
). Labeled membranes
were viewed and photographed using a Zeiss epifluorescence photo
microscope III RS with a 100 W DC mercury lamp (Carl Zeiss, Thornwood,
NY).
Fractionation
Triton X-100 extraction and sucrose gradient centrifugation of
cells were performed as described by Lisanti and colleagues (S.W. Li
et al., 1995
). Detergent-free caveolae were prepared on
OptiPrep gradients (fibroblast, MDCK, and MA104 cells) by the method of
Smart et al. (1995b)
. S49 cells (harvested at 2-4 × 106 cells/ml) were disrupted by nitrogen cavitation (3 × 107 cells/ml), and plasma membranes were collected from
the interfacial areas of 20/30% and 30/40% sucrose step gradients as
described (Ross et al., 1977
). Two milligrams of S49 cell
membranes were suspended in 23% OptiPrep and applied below a linear
OptiPrep gradient as described (Smart et al., 1995b
).
Adenylyl Cyclase Assay
Enzyme activity was quantified as described (Salomon et
al., 1974
; Smigel, 1986
). Samples were assayed in a volume of 100 µl (S49) or 200 µl (fibroblasts) for 30 min at 30°C in the
presence of 10 mM MgCl2. [
-32P]ATP was
purchased from DuPont NEN (Boston, MA). Five micrograms of S49 cell
plasma membranes isolated from the sucrose gradients were assayed as a
control for several experiments. These plasma membranes had basal
adenylyl cyclase-specific activities of 0.03 ± 0.01 nmol/min/mg
protein. Activity was raised four- to eightfold by 2 µM isoproterenol
and 15 µM guanosine triphosphate (GTP) (0.12 ± 0.03 nmol/min/mg) or 50 µM forskolin (0.23 ± 0.09 nmol/min/mg).
Electron Microscopy
Plasma membranes were isolated from the upper surface of cells
by the method of Sanan and Anderson (1991)
. Immunogold labeling was
performed on plasma membranes that had been fixed in 3%
paraformaldehyde. Secondary antibodies (goat anti-mouse or anti-rabbit
from Zymed Laboratories, Inc., South San Francisco, CA) were diluted to
50 µg/ml. Rabbit anti-goat 10 nm gold conjugate (Sigma Chemical, St.
Louis, MO) was used at 2 × 1011 particles per ml.
Grids were viewed and photographed using a JEOL JEM-100CX electron
microscope.
Construction of Transfer and Expression Vectors
The vector for stable expression of
o in MDCK
cells was synthesized by inserting cDNA encoding rat
o
(from clone 31 in pGEM2 provided by Dr. Randall Reed, Johns Hopkins,
Baltimore, MD) (Jones and Reed, 1987
) into the BglII and
EcoRI sites of pCB6+ (Brewer, 1994
). A
full-length cDNA encoding rat VIP21/
-caveolin-1 in pBluescript
(Kurzchalia et al., 1992
) was kindly provided by Drs. D. Zacchetti and K. Simons (European Molecular Biological Laboratory,
Heidelberg, Germany).
-Caveolin-1, tagged with six histidine
residues at the amino terminus (NH6-caveolin), was
generated by synthesizing an oligonucleotide cassette for substitution
insertion. This cassette encodes an initiator ATG followed by six
histidines and the first seven amino acid residues of caveolin;
NotI and AccI sites were placed at its 5
and 3
ends, respectively. After annealing, the cassette was subcloned into
the unique AccI site near the extreme amino terminus of the
caveolin-coding region and the 5
NotI site of pBluescript
(Strategene, La Jolla, CA). The resulting plasmid was linearized with
XhoI, end-filled with Klenow fragment, and then digested
with NotI to yield a fragment containing the full-length
NH6-caveolin-coding sequence. This fragment was subcloned
into the NotI and SmaI sites of the Sf9 baculovirus expression vector pVL1392 (Summers and Smith, 1987
) to
yield a transfer vector encoding full-length
-caveolin-1 (Sf9 NH6:FL-caveolin). FL-caveolin or the first 101 amino-terminal residues of caveolin (NT-caveolin) were also fused to
the carboxyl terminus of glutathione S-transferase (GST) for
expression in Escherichia coli. Three oligonucleotides were
designed for use in polymerase chain reaction amplification of
caveolin: Oligo 1, a sense oligonucleotide encoding an XbaI
site in frame with the first thirty 5
coding bases of
-caveolin;
oligo 2, an antisense oligonucleotide encoding bases 273-303, a
glycine and six histidines, followed by a stop codon and a
HindIII site; oligo 3, an antisense oligonucleotide encoding
bases 507-534 and a hexahistidine tag at the carboxyl terminus
followed by a stop codon and a HindIII site. Oligo 1 and
oligo 2 were used to generate, by polymerase chain reaction
amplification, a DNA fragment encoding NT-caveolin with a hexahistidine
tag appended to the carboxyl terminus. Oligos 1 and 3 were used to
generate a DNA fragment encoding full-length caveolin with a
hexahistidine tag appended to the carboxyl terminus. These fragments
were each digested with XbaI and HindIII and
subcloned into the pGEX-2T (Pharmacia Biotechnology, Piscataway, NJ)
vector in frame with GST to yield an E. coli expression
vector that encoded full-length
-caveolin-1 fused to the carboxyl
terminus of GST (GST-FL-caveolin:CH6) or the amino-terminal
101 residues of
-caveolin-1 (GST-NT-caveolin:CH6), each
with a hexahistidine tag at the carboxyl terminus (CH6).
The nucleotide sequence of all caveolin constructs was confirmed by dye
terminator sequencing using an Applied Biosystems 373A automated
sequencer (Perkin Elmer-Cetus, Foster City, CA).
Purification of Caveolin and GST-Caveolin Fusion Proteins
Sf9 NH6:FL-caveolin was extracted from recombinant
virus-infected Sf9 membranes (3.5 mg/ml protein) by addition of TX-100 to 1% (vol/vol) and isolated by Ni-NTA affinity chromatography (Qiagen, Santa Clarita, CA). The highly enriched
NH6:FL-caveolin recovered from the first column was
purified to near homogeneity by Q-Sepharose anion exchange
chromatography as described (Hepler et al., 1996
).
GST-FL-caveolin:CH6 and GST-NT-caveolin:CH6
expressed in E. coli were purified by sequential Ni-NTA and
glutathione-agarose affinity chromatography and were judged to be
greater than 95% pure by SDS-PAGE and Coomassie blue staining. These
proteins were used for experiments shown in Figures 8 and 9.
GST-caveolin constructs without the CH6 tag were also
synthesized, but they yielded proteins from glutathione-agarose that
appeared (by Western immunoblotting) to have been
proteolyzed to varying extents and were thus considered poor candidates
for further analysis.
|
|
Preparation of G Proteins and G Protein Binding to GST-NT-Caveolin Affinity Resin
Myristoylated
o was synthesized in E. coli and purified as described (Linder and Mumby, 1994
). To
examine G protein binding to GST-caveolin:CH6, protein
affinity resins were prepared following a published procedure (S.W. Li
et al., 1995
). Analysis of starting material (load samples),
bound, and recovered GST and GST-NT-caveolin:CH6 proteins
indicated that essentially all of the applied GST fusion proteins bound
to the glutathione-agarose (not shown). Purified G proteins were
incubated with GST-agarose, GST-FL-caveolin:CH6, or
GST-NT-caveolin:CH6-agarose overnight at 4°C to
facilitate G protein interaction with caveolin. Unbound material,
washes, and eluted proteins were analyzed by immunoblot
analysis using G protein antibodies or goat anti-GST (Pharmacia,
Piscataway, NJ). No G protein subunits,
GST-NT-caveolin:CH6, or GST remained bound to the agarose
after glutathione elutions as assessed by immunoblot
analysis of resin boiled in SDS-PAGE sample buffer (not shown).
Preparation and Analysis of Caveolin Peptide and Steady State GTP Hydrolysis Assays
A 20-amino acid peptide corresponding to
-caveolin-1 residues
82-101 (DGIWKASFTTFTVTKYWFYR) was synthesized in the Howard Hughes
Medical Institute Biopolymer Facility at the University of Texas
Southwestern Medical Center. The identity and purity of the peptide was
confirmed by high pressure liquid chromatography and mass spectral
analysis. This peptide was identical in sequence to the peptide
designated caveolin-2 by Lisanti and co-workers (S.W. Li et
al., 1995
). Peptide was solubilized in water and further resolved
from low molecular weight impurities by size exclusion chromatography;
recovered peptide was detected and quantified by measurement of the
optical density at 280 nm. This peptide and the purified caveolin
proteins were assayed for their effects on the steady-state rate of
hydrolysis of [
-32P-GTP] (Hepler et al.,
1996
). Guanosine triphosphatase (GTPase) reactions were carried out in
a final assay volume of 50 µl. Myristoylated
o was
incubated together with either G
alone or together with Sf9
FL-NH6:caveolin, GST-FL-caveolin:CH6,
GST-NT-caveolin:CH6, or caveolin peptide for 15 min at
4°C in reaction buffer (20 mM HEPES, pH 8, 1 mM EDTA, 1 mM
dithiothreitol, 0.5 mM MgSO4, 0.05% C12E10). Duplicate reactions were started by
addition of 30 µl of reaction buffer containing 1.67 µM
[32P]GTP (50 pmol GTP/assay final; 10,000-15,000
cpm/pmol) and incubating samples for 20 min at 30°C. Reactions were
terminated by addition of 750 µl of a Norit A-activated charcoal
suspension (5% in 50 mM NaH2PO4). Samples were
centrifuged and 500 µl of supernatant fraction were assayed for the
presence of inorganic [32P]phosphate by liquid
scintillation counting. These experiments were conducted twice with
similar results obtained.
| |
RESULTS |
|---|
|
|
|---|
Antibody Specificity
The specificities of the antibody preparations employed for
Western immunoblotting, immunofluorescence, and
immunogold labeling of
i and caveolin are summarized in
Figure 1 and MATERIALS AND METHODS. The reactivity of peptide
antibodies A569 and B087 with purified G protein
subunits is shown
in Figure 1A; the specificity of monoclonal antibody R4 for
i1 has been demonstrated previously (X. Li et
al., 1995
). The antibodies to G protein
subunits interact selectively with
i in crude membrane preparations
(Figure 1B), and they are thus useful reagents for immunolocalization
experiments.
Immunofluorescence
We examined the distribution of
i on the inner face
of isolated plasma membranes (prepared by sonicating cells adherent to coverslips) by immunofluorescence. Antibodies to G protein
i or
subunits revealed punctate patterns of
immunofluorescent staining suggesting a concentration of these proteins
at distinct sites on the plasma membrane (Figure
2). We compared the distribution of
i with caveolin by conducting double immunofluorescence
on plasma membranes prepared from three different cultured cell types: MDCK and MA104 cells [renal epithelial cells that have been used previously for isolation and functional characterization of caveolae (Anderson et al., 1992
; Sargiacomo et al., 1993
;
Smart et al., 1994
, 1995a
)] and primary human fibroblasts
(which have excellent morphological characteristics and many
invaginated caveolae). Although there are clearly areas where the
patterns of fluorescence are coincidental, consistent with
colocalization of the two proteins, the coincidence is not complete
(Figure 3). The extent of colocalization appeared to be considerably less for fibroblasts than for the two
epithelial cell lines. The punctate patterns for both proteins are
composed of dots that are generally smaller and more variable in size
than those observed with antibodies to clathrin, which is localized in
coated pits (data not shown). G proteins did not appear colocalized
appreciably with clatherin in double immunofluorescence experiments
with antibodies to both proteins (not shown). The fluorescent dots that
represent
i often appear finer than those for caveolin,
and they can be so closely juxtaposed that it is difficult to reproduce
them faithfully for publication. Similar patterns were observed with
different antibodies to
i or caveolin; the pattern for
i was indistinguishable with antibodies P960 (Casey
et al., 1990
), A569, B087, and R4. Fluorescence was not observed if antibodies to the G proteins were first incubated with immunogen peptide (or relevant G protein subunit), whereas the
staining pattern was preserved if the antibodies were incubated with a
nonreactive G protein subunit or peptide (not shown).
|
|
Subcellular Fractionation of G Proteins, Caveolin, and Adenylyl Cyclase Activity
Methods designed to isolate low-density membrane fractions from
tissues or cultured cells have permitted enrichment of both G proteins
and caveolin. MDCK cells, Triton X-100 extraction, and sucrose
gradients have been employed frequently by others (Sargiacomo et
al., 1993
; Lisanti et al., 1994b
; S.W. Li et
al., 1995
; Song et al., 1996
) with results similar to
those shown in Figure 4. Most of the
cellular proteins (assayed by Ponceau S staining of the blot, not
shown) remained in the region where the Triton X-100 extract was loaded
at the bottom of the tube (fractions 8-11), while Triton
X-100-insoluble membranes of low density floated up into the sucrose
gradient (lower numbered fractions). Immunoblotting
revealed that endogenous
i and
subunits, exogenously expressed
o protein, and the bulk of the caveolin
fractionated closely together. G proteins and caveolin (from MDCK
cells) also fractionated together when this procedure was modified by
replacement of detergent with sodium carbonate, pH 11 (Song et
al., 1996
) (not shown).
|
An alternative method of fractionation involves floatation of plasma
membrane-containing fractions (from a Percoll gradient) through a
continuous gradient of OptiPrep (Smart et al., 1995b
). Endogenous G protein
i subunits and
subunits, as
well as exogenously expressed
o protein, did not
cofractionate completely with caveolin through the OptiPrep gradients.
We routinely observed that a substantial portion of G protein migrated
into lower density fractions than did caveolin. These observations were
made for MDCK cells (Figure 5A-C), MA104
cells (not shown), and fibroblasts (not shown) and are consistent with
the results of double immunofluorescence experiments shown in Figure 3.
|
We extended our fractionation studies to S49 lymphoma cells because
they lack detectable caveolin (by immunoblotting) and have been utilized extensively to study G protein-mediated signal transduction. The lack of caveolin in these cells is consistent with
reports from others who have studied lymphocytes (Fra et al., 1994
). Plasma membranes from these cells were fractionated by
the OptiPrep method (Figure 5, D and E), with results similar to those
obtained with MDCK cells (Figure 5, A-C). G protein subunits (
i, both long and short isoforms of
s,
and
) were found in fractions that migrated up into the gradient and
were resolved from the bulk of the protein (Figure 5E). Although
antibodies of sufficient quality to detect
-adrenergic receptors and
adenylyl cyclase in these fractions are not available, the highest
specific activities of
-adrenergic receptor- and
forskolin-stimulated cAMP synthesis were found in fractions 3-6
(Figure 5F). Thus, all components of a hormone-sensitive adenylyl
cyclase system are present in membrane fractions with low densities and
can be separated from the bulk of the plasma membrane protein prepared on sucrose gradients from cells that do not contain caveolin. Similar
results were obtained for fibroblasts. The highest total activity of
forskolin-stimulated adenylyl cyclase in fibroblast membranes was
present in fractions 3-7 (Figure 6B),
and the highest specific activity was found in fractions 3-6 (Figure
6C). Fibroblast G proteins were found (by Western
immunoblotting, not shown) evenly spread, as in MDCK
cells (Figure 5, B and C), over more fractions (1-8) than was the bulk
of caveolin (not shown) and adenylyl cyclase activity (Figure 6B).
Isoproterenol-stimulated adenylyl cyclase activity was not detected in
membranes from fibroblasts. Depending on the cell type and variations
between independent experiments, 50-80% of total adenylyl cyclase
activity was found in fractions 1-6 whereas only 15-20% of total
plasma membrane protein was present in these fractions.
|
Immunogold Electron Microscopy
We examined plasma membranes of fibroblasts and other cells to
determine sites of localization of
i and to evaluate the
extent to which this protein is associated with morphologically
recognizable caveolae. Similar immunogold labeling patterns were
obtained with peptide antibodies directed to two different regions of
i (Figure 7B and C). This
pattern differed from that obtained with an anti-caveolin antibody
(Figure 7A). Both anti-
i antibodies yielded clusters of
gold particles that were most frequently associated with structures of
irregular shape and size that we were unable to identify. Coated pits
were not labeled by
i antibodies (Figure 7, B and C)
consistent with our double immunofluorescence results with clathrin
antibodies (not shown). Immunogold labeling of
i was
reduced dramatically (74-88% in two experiments) when the primary
antibodies were combined with the immunogen peptide but not with an
irrelevant peptide. Only about 10-20% of morphologically identifiable
caveolae in fibroblasts were labeled by
i antibodies
(see solid arrows, Figure 7; Table 1). By
contrast, essentially all of the morphologically identifiable
(invaginated, doughnut-shaped) caveolae were labeled by the preparation
of caveolin antibodies. Similar patterns of immunogold staining of
i were also seen with plasma membranes of MDCK and MA104
cells, although fewer invaginated caveolae could be identified (not
shown).
|
|
Invaginated caveolae are not evenly distributed on the fibroblast
plasma membrane, and we sought to determine whether
i is enriched in areas that have high densities of these membrane
specializations. Square micron areas of the plasma membrane that were
obviously caveolae-rich or caveolae-poor were chosen arbitrarily for
counting the total number of caveolae and the total number of gold
particles observed after labeling with either
i or
caveolin antibodies. As expected, the caveolin antibody yielded total
numbers of gold particles in the caveolae-rich areas that were 10- to
20-fold greater than those in the caveolae-poor areas (Table
2). By contrast, immunogold labeling with
either of two
i antibodies was greater in areas of
plasma membrane that were relatively poor in invaginated caveolae.
|
Interaction of Caveolin with G Proteins
Caveolin has been proposed to act as a scaffold that localizes G
proteins to caveolae and, further, as a regulator of the activity of
these signal transducers (S.W. Li et al., 1995
; Scherer et al., 1996
; Tang et al., 1996
, 1997
). Li, S.W.
et al. (1995) demonstrated qualitatively that recombinant G
protein
subunits (
o and
i2) from
extracts of transfected MDCK or baculovirus-infected Sf21 insect cells
bind to GST-FL-caveolin or GST-NT-caveolin. Because these experiments
were not performed with purified proteins, the interaction of
subunits with the caveolin constructs could have been indirect or
require additional factors. If G proteins bind to caveolin directly,
pure
subunits should bind to GST-caveolin attached to glutathione
agarose beads. We investigated such binding with pure myristoylated
o in the presence or absence of 
. The
o and 
appeared to be quantitatively recovered in
the flow through and first wash of the GST-caveolin resins in a manner indistinguishable from GST without appended caveolin (Figure
8A for GST-NT-caveolin:CH6;
GST-FL-caveolin:CH6 not shown). Only after prolonged
exposure of the blot to film could we detect a hint of
o
in the glutathione elution from the GST-NT-caveolin:CH6 agarose (Figure 8B), and we estimate that the eluted material represented much less than 1% of that added to the caveolin
constructs. In experiments conducted similarly to those published (S.W.
Li et al., 1995
), we were unable to detect binding of
recombinantly expressed unpurified
o or
i2 (from extracts of baculovirus-infected Sf9 cells) to
FL-caveolin:CH6 (data not shown). Thus, we were unable to
demonstrate a substantial interaction between G protein subunits and
caveolin in the presence or absence of other cellular components.
It has been reported that synthetic peptides corresponding to specific
regions of caveolin (e.g., residues 82-101 of caveolin-1) modulate the
basal GTPase activity of
i and
o and
alter binding of GTP
S to these proteins (S.W. Li et al.,
1995
; Scherer et al., 1996
; Tang et al., 1996
,
1997
). If these represent physiologically relevant reactions, intact
caveolin should cause similar effects. We found that neither the
caveolin-1 peptide (reported to inhibit GTPase activity), Sf9
NH6:FL-caveolin, GST-FL-, nor
GST-NT-caveolin:CH6 influenced the basal GTPase activity of
o significantly in the presence or absence of 
(Figure 9); the inhibitory effect of 
on the GTPase activity of
o is characteristic
(Figure 9A, hatched bars). We also failed to observe effects of the
peptide or proteins on binding of GTP
S to
o (not
shown). Finally, we tested two other peptides that were said to
modulate GTPase activity (Scherer et al., 1996
; Tang
et al., 1996
). These peptides represent regions of
caveolin-2 and caveolin-3 isoforms that correspond to the caveolin-1
sequence specified above. These two peptides were difficult to
solubilize and gave irreproducible results. In summary, we cannot
reproduce the published effects of caveolin peptides on the GTPase
activity of
o or on GTP
S binding to the protein, and
we also observe no effects of FL- or NT-caveolin on these parameters.
| |
DISCUSSION |
|---|
|
|
|---|
Individual cells express an imposing array of proteins that
participate in G protein-mediated signal transduction reactions: a
large number of receptors; a substantial variety of G protein
,
,
and
subunits; many distinct effectors that exist in multiple isoforms; and regulators such as members of the large families of
receptor kinases, arrestins, regulators of G protein signaling (RGS)
proteins, and probably others. Although the critical phenomena that
result from the interactions between these components can and at times
must be studied using purified proteins reconstituted in vitro, other
aspects of G protein-mediated signaling are not yet observable in such
well-defined systems. For example, the magnitude of stimulation of
adenylyl cyclase activity by appropriate hormones is much greater in
intact cells than in membranes; the specificity of receptor-G protein
interactions in reconstituted systems appears to be less stringent than
that observed in membranes or cells; requirements for specific
combinations of isoforms of G protein subunits to observe appropriate
responses to individual receptor agonists cannot yet be duplicated in
vitro (Neubig, 1994
). These and other phenomena suggest the possibility
of or need for nonrandom, functional organization of these components
in the plasma membrane to achieve the requisite speed, magnitude of
response, functional specificity, and regulation that characterize
these systems.
A substantial fraction of the total activity and the highest specific
activity of isoproterenol-stimulated adenylyl cyclase activity in S49
cells was found in low-density subfractions of the plasma membrane with
buoyant properties similar to those of caveolae (Figure 5F). Thus,
Gs-coupled receptors, Gs itself, and adenylyl
cyclase appear to be localized in similar domains
perhaps together
to increase the efficiency and fidelity of signal transduction at
distinct sites on the plasma membrane. In this regard, investigators have come to different conclusions about the distribution of endogenous
-adrenergic receptors in the plasma membrane. Some have indicated that the distribution of unstimulated receptors was random and homogeneous (Kaveri et al., 1987
; Muntz et al.,
1988
; Raposo et al., 1989
), while others have observed
nonrandom patterns (Zemick and Strader, 1988
; Wang et al.,
1989
). Cytochemical experiments have also suggested that adenylyl
cyclase activity is associated with structures resembling caveolae
(Wagner et al., 1972
; Slezak and Geller, 1984
; Rechardt and
Hervonen, 1985
).
We and others (Wang et al., 1989
; Lewis et al.,
1991
) have focused on G proteins and found them to be clustered at the
inner surface of the plasma membrane, indicating their concentration at
particular sites. Our membrane fractionation data indicate localization
of G proteins in low-density subfractions of the plasma membrane and
are consistent with colocalization of a substantial fraction of G
protein subunits with caveolin. These experiments are at least
semiquantitative, in that all of a particular G protein subunit in the
cell can presumably be detected by immunoblotting after
denaturation; however, the resolution of this technique is relatively
low. Immunofluorescence experiments indicate that there is significant
colocalization of G protein subunits and caveolin, but that it is
incomplete and variable among cell types. This is consistent with
recent reports demonstrating coimmunoprecipitation of G proteins
or related signaling components with caveolin using cell extracts (Chun
et al., 1994
), some of which included
detergent-insoluble particles (de Weerd and Leeb-Lundberg, 1997
; Feron
et al., 1997
). Incomplete and/or cell type-dependent
colocalization of G proteins and caveolin may explain the results of
Stan et al. (1996)
, who concluded that G proteins are not
enriched in caveolae. Although this may be true in the cells studied,
those of rat lung vasculature, the techniques utilized for isolation of
caveolae (perfusion of lung with cationized silica and the
immunoisolation of caveolin-containing membranes) may have altered the
distribution of the proteins in question. Our electron microscopy
studies suggest that most of the G protein
i subunits
reside in irregular structures that could not be identified. Although
the resolution of the microscopic techniques is of course intrinsically
high, quantitation can be lost. It is possible that populations of G
protein subunits are not visualized in these experiments because of
fixation artifacts or masking of epitopes. These caveats aside, we
would conclude that morphologically distinct, invaginated caveolae are
a minor location of
i in the cells we studied by
electron microscopy.
Caveolin per se is not required for localization of G
proteins in low-density subfractions of the plasma membrane (Figure 5E). In this regard we must question a premise for colocalization of
caveolin and G proteins
direct protein-protein interactions. We
were unable to observe interactions between G protein
or 
subunits and caveolin, and we were unable to detect functional effects
of caveolin or caveolin-based peptides on guanine nucleotide binding or
hydrolysis of G protein subunits. Our use of recombinant myristoylated
o purified from bacteria (protein that could lack important covalent adducts such as palmitate), may have prevented our
detection of a substantial direct interaction between G proteins and
caveolin. We are unable to explain why, in experiments conducted similarly to those published (S.W. Li et al., 1995
), we did
not detect interaction between caveolin and unpurified
o
or
i2 from extracts of baculovirus-infected Sf9 cells
(in which G proteins are properly palmitoylated) or effects of
caveolin-based peptides on G protein function.
Our working hypothesis on localization is that G proteins in particular
(and probably entire G protein-coupled signaling systems) are not
randomly distributed in the plasma membrane but are physically and
functionally segregated into distinct membrane domains. If caveolae are
defined narrowly as caveolin-containing invaginations of the plasma
membrane (Simons and Ikonen, 1997
) then we conclude that these
structures are not the predominant location of
i [Table 1 and Stan et al., (1996)
]. If, instead, caveolae are
defined more broadly as a membrane system that includes low-density
subdomains of the plasma membrane (Anderson, 1998
), then our data
show that such structures are major sites for localization of G
proteins and adenylyl cyclase. Using this definition, caveolae may be
similar or identical to the protein-containing clusters of
glycosphingolipids and cholesterol that Simons and Ikonen (1997)
have
described as mobile rafts within the fluid membrane bilayer. It would
be of great interest to examine the signaling properties of cells in which these structures were specifically disrupted.
| |
ACKNOWLEDGMENTS |
|---|
We thank Yun-shu Ying and Hsin Chieh Lin for advice and assistance with the immunocytochemical procedures. S.M. acknowledges the contribution of Kathryn H. Muntz in the beginning of the immunocytochemical work. Technical assistance was skillfully provided by Erin Reid, Helen Aronovich, and Linda Hannigan. This work was supported by grants from the National Institute of General Medical Sciences to S.M. (GM-50515), A.G.G. (GM-34497), and R.A. (GM-52016); the National Institute of Heart and Lung to R.A. (HL-20948); and the American Heart Association Texas Affiliate to J.H. (94G-112). Support from the Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology to A.G.G. and the Perot Family Trust to R.A. is also acknowledged.
| |
FOOTNOTES |
|---|
¶ Corresponding author.
Current address: Department of Pharmacology, Emory
University School of Medicine, Atlanta, GA 30322.
1
Abbreviations used:
i,
o, and
s,
subunits of heterotrimeric
G proteins Gi, Go, and Gs,
respectively;
,
subunit of heterotrimeric G protein;
CH6, carboxy-terminal hexahistidine tag; FL-caveolin,
full-length caveolin;
, gamma subunit of heterotrimeric G protein;
GST, glutathione S-transferase; MDCK, Madin Darby canine kidney; NH6, amino-terminal hexahistidine tag; NT-caveolin,
amino-terminal 101 amino acids of caveolin.
| |
REFERENCES |
|---|
|
|
|---|
subunits G
q and G
i in caveolae in DDT1 MF-2 smooth muscle cells.
J. Biol. Chem.
272, 17858-17866
.
J. Biol. Chem.
271, 496-504
2-adrenergic receptor recognize two major polypeptide chains.
Eur. J. Biochem.
167, 449-456[Medline].
subunits in Escherichia coli.
Methods Enzymol.
237, 146-164[Medline].
subunit(s) of Gi: visualization by immunofluorescent and immunogold labeling.
Cell Regul.
2, 1097-1113[Medline].
-subunits: production of monoclonal antibodies and detection of differential increases on differentiation of PC12 and LA-N-5 cells.
J. Neurochem.
64, 1107-1117[Medline].
subunits are palmitoylated.
Proc. Natl. Acad. Sci. USA
90, 3675-3679
subunits.
Methods Enzymol.
237, 254-268[Medline].
40 and
41 subunits of guanine nucleotide-binding regulatory proteins from bovine brain.
J. Biol. Chem.
263, 2020-2026
subunit expression, myristoylation, and membrane association in COS cells.
Proc. Natl. Acad. Sci. USA
87, 728-732
or
subunits.
Methods Enzymol.
195, 215-233[Medline].
-adrenergic receptor using a ferritin-alprenolol probe.
Mol. Pharmacol.
34, 444-451[Abstract].
subunit prenylation on association of guanine nucleotide-binding regulatory proteins with membranes.
Mol. Biol. Cell
3, 49-61[Abstract].
-adrenergic receptor in A431 cells involves non-coated vesicles.
Eur. J. Cell Biol.
50, 340-352[Medline].
-adrenergic receptor and adenylate cyclase. Studies of ligand binding and enzyme activity in purified membranes of S49 lymphoma cells.
J. Biol. Chem.
252, 5761-5775
-adrenergic receptors and G proteins in human A431 cells.
Biochem. J.
263, 519-532[Medline].
-adrenergic receptor on DDT-1 cells.
Biochem. J.
251, 333-339[Medline].
This article has been cited by other articles:
![]() |
C.-L. Hu, R. Chandra, H. Ge, J. Pain, L. Yan, G. Babu, C. Depre, K. Iwatsubo, Y. Ishikawa, J. Sadoshima, et al. Adenylyl cyclase type 5 protein expression during cardiac development and stress Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1776 - H1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Means, S. Miyamoto, J. Chun, and J. H. Brown S1P1 Receptor Localization Confers Selectivity for Gi-mediated cAMP and Contractile Responses J. Biol. Chem., May 2, 2008; 283(18): 11954 - 11963. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Willoughby and D. M. F. Cooper Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains Physiol Rev, July 1, 2007; 87(3): 965 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Awasthi, S. K. Mandal, V. Papanna, L. V. M. Rao, and U. R. Pendurthi Modulation of Tissue Factor-Factor VIIa Signaling by Lipid Rafts and Caveolae Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1447 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Head, H. H. Patel, D. M. Roth, F. Murray, J. S. Swaney, I. R. Niesman, M. G. Farquhar, and P. A. Insel Microtubules and Actin Microfilaments Regulate Lipid Raft/Caveolae Localization of Adenylyl Cyclase Signaling Components J. Biol. Chem., September 8, 2006; 281(36): 26391 - 26399. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Piggott, K. A. Hassell, Z. Berkova, A. P. Morris, M. Silberbach, and T. C. Rich Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments J. Gen. Physiol., June 26, 2006; 128(1): 3 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Urs, K. T. Jones, P. D. Salo, J. E. Severin, J. Trejo, and H. Radhakrishna A requirement for membrane cholesterol in the {beta}-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors J. Cell Sci., November 15, 2005; 118(22): 5291 - 5304. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Head, H. H. Patel, D. M. Roth, N. C. Lai, I. R. Niesman, M. G. Farquhar, and P. A. Insel G-protein-coupled Receptor Signaling Components Localize in Both Sarcolemmal and Intracellular Caveolin-3-associated Microdomains in Adult Cardiac Myocytes J. Biol. Chem., September 2, 2005; 280(35): 31036 - 31044. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rudajev, J. Novotny, L. Hejnova, G. Milligan, and P. Svoboda Dominant Portion of Thyrotropin-Releasing Hormone Receptor Is Excluded from Lipid Domains. Detergent-Resistant and Detergent-Sensitive Pools of TRH Receptor and Gq{alpha}/G11{alpha} Protein J. Biochem., August 1, 2005; 138(2): 111 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dyer, Y. Liu, I. P. de la Huerga, and C. W. Taylor Long Lasting Inhibition of Adenylyl Cyclase Selectively Mediated by Inositol 1,4,5-Trisphosphate-evoked Calcium Release J. Biol. Chem., March 11, 2005; 280(10): 8936 - 8944. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kolachala, V. Asamoah, L. Wang, S. Srinivasan, D. Merlin, and S. V. Sitaraman Interferon-{gamma} Down-regulates Adenosine 2b Receptor-mediated Signaling and Short Circuit Current in the Intestinal Epithelia by Inhibiting the Expression of Adenylate Cyclase J. Biol. Chem., February 11, 2005; 280(6): 4048 - 4057. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Gratton, P. Bernatchez, and W. C. Sessa Caveolae and Caveolins in the Cardiovascular System Circ. Res., June 11, 2004; 94(11): 1408 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Sadler and N. D. Jacobs Stimulation of Xenopus laevis Oocyte Maturation by Methyl-{beta}-Cyclodextrin Biol Reprod, June 1, 2004; 70(6): 1685 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Goel, P. J. Phillips-Mason, A. Gardner, D. M. Raben, and J. J. Baldassare {alpha}-Thrombin-mediated Phosphatidylinositol 3-Kinase Activation through Release of G{beta}{gamma} Dimers from G{alpha}q and G{alpha}i2 J. Biol. Chem., February 20, 2004; 279(8): 6701 - 6710. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Papoucheva, A. Dumuis, M. Sebben, D. W. Richter, and E. G. Ponimaskin The 5-Hydroxytryptamine(1A) Receptor Is Stably Palmitoylated, and Acylation Is Critical for Communication of Receptor with Gi Protein J. Biol. Chem., January 30, 2004; 279(5): 3280 - 3291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. TASKEN and E. M. AANDAHL Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A Physiol Rev, January 1, 2004; 84(1): 137 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Elenko, T. Fischer, I. Niesman, T. Harding, T. McQuistan, M. Von Zastrow, and M. G. Farquhar Spatial Regulation of G{alpha}i Protein Signaling in Clathrin-Coated Membrane Microdomains Containing GAIP Mol. Pharmacol., July 1, 2003; 64(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Rybin, E. Pak, S. Alcott, and S. F. Steinberg Developmental Changes in {beta}2-Adrenergic Receptor Signaling in Ventricular Myocytes: the Role of Gi proteins and Caveolae Microdomains Mol. Pharmacol., June 1, 2003; 63(6): 1338 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Baker, H. Zheng, J. Walker, J. L. Coloff, and J. E. Buss Distinct Rates of Palmitate Turnover on Membrane-bound Cellular and Oncogenic H-Ras J. Biol. Chem., May 23, 2003; 278(21): 19292 - 19300. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Pike Lipid rafts: bringing order to chaos J. Lipid Res., April 1, 2003; 44(4): 655 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Smith, C. Gu, K. A. Fagan, B. Hu, and D. M. F. Cooper Residence of Adenylyl Cyclase Type 8 in Caveolae Is Necessary but Not Sufficient for Regulation by Capacitative Ca2+ Entry J. Biol. Chem., February 15, 2002; 277(8): 6025 - 6031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Dunphy, W. K. Greentree, and M. E. Linder Enrichment of G-protein Palmitoyltransferase Activity in Low Density Membranes. IN VITRO RECONSTITUTION OF Galpha i TO THESE DOMAINS REQUIRES PALMITOYLTRANSFERASE ACTIVITY J. Biol. Chem., November 9, 2001; 276(46): 43300 - 43304. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Donati, C. Thukral, and M. M. Rasenick Chronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsalpha Mol. Pharmacol., June 1, 2001; 59(6): 1426 - 1432. [Abstract] [Full Text] |
||||
![]() |
P. Oh and J. E. Schnitzer Segregation of Heterotrimeric G Proteins in Cell Surface Microdomains. Gq Binds Caveolin to Concentrate in Caveolae, whereas Gi and Gs Target Lipid Rafts by Default Mol. Biol. Cell, March 1, 2001; 12(3): 685 - 698. [Abstract] [Full Text] |
||||
![]() |
T. Vang, K. M. Torgersen, V. Sundvold, M. Saxena, F. O. Levy, B. S. Skalhegg, V. Hansson, T. Mustelin, and K. Tasken Activation of the Cooh-Terminal Src Kinase (Csk) by Camp-Dependent Protein Kinase Inhibits Signaling through the T Cell Receptor J. Exp. Med., February 19, 2001; 193(4): 497 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Lai, D. M. Roth, M. H. Gao, S. Fine, B. P. Head, J. Zhu, M. D. McKirnan, C. Kwong, N. Dalton, K. Urasawa, et al. Intracoronary Delivery of Adenovirus Encoding Adenylyl Cyclase VI Increases Left Ventricular Function and cAMP-Generating Capacity Circulation, November 7, 2000; 102(19): 2396 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rebecchi and S. N. Pentyala Structure, Function, and Control of Phosphoinositide-Specific Phospholipase C Physiol Rev, October 1, 2000; 80(4): 1291 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Rich, K. A. Fagan, H. Nakata, J. Schaack, D. M.F. Cooper, and J. W. Karpen Cyclic Nucleotide-Gated Channels Colocalize with Adenylyl Cyclase in Regions of Restricted Camp Diffusion J. Gen. Physiol., August 1, 2000; 116(2): 147 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. McAllister, J. A. Stanton, K. Salim, E. J. Handford, and M. S. Beer Edg2 Receptor Functionality: Gialpha 1 Coexpression and Fusion Protein Studies Mol. Pharmacol., August 1, 2000; 58(2): 407 - 412. [Abstract] [Full Text] |
||||
![]() |
R. S. Ostrom, J. D. Violin, S. Coleman, and P. A. Insel Selective Enhancement of beta -Adrenergic Receptor Signaling by Overexpression of Adenylyl Cyclase Type 6: Colocalization of Receptor and Adenylyl Cyclase in Caveolae of Cardiac Myocytes Mol. Pharmacol., May 1, 2000; 57(5): 1075 - 1079. [Abstract] [Full Text] |
||||
![]() |
M. L. Bayewitch, I. Nevo, T. Avidor-Reiss, R. Levy, W. F. Simonds, and Z. Vogel Alterations in Detergent Solubility of Heterotrimeric G Proteins after Chronic Activation of Gi/o-Coupled Receptors: Changes in Detergent Solubility Are in Correlation with Onset of Adenylyl Cyclase Superactivation Mol. Pharmacol., April 1, 2000; 57(4): 820 - 825. [Abstract] [Full Text] |
||||
![]() |
R. D. Lasley, P. Narayan, A. Uittenbogaard, and E. J. Smart Activated Cardiac Adenosine A1 Receptors Translocate Out of Caveolae J. Biol. Chem., February 11, 2000; 275(6): 4417 - 4421. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Moffett, D. A. Brown, and M. E. Linder Lipid-dependent Targeting of G Proteins into Rafts J. Biol. Chem., January 21, 2000; 275(3): 2191 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Speed and C. Mitchell Sustained elevation in inositol 1,4,5-trisphosphate results in inhibition of phosphatidylinositol transfer protein activity and chronic depletion of the agonist-sensitive phosphoinositide pool J. Cell Sci., January 7, 2000; 113(14): 2631 - 2638. [Abstract] [PDF] |
||||
![]() |
Y. Wang, R. T. Windh, C. A. Chen, and D. R. Manning N-Myristoylation and beta gamma Play Roles beyond Anchorage in the Palmitoylation of the G Protein alpha o Subunit J. Biol. Chem., December 24, 1999; 274(52): 37435 - 37442. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Smart, G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti Caveolins, Liquid-Ordered Domains, and Signal Transduction Mol. Cell. Biol., November 1, 1999; 19(11): 7289 - 7304. [Full Text] [PDF] |
||||
![]() |
M. Waldhoer, A. Wise, G. Milligan, M. Freissmuth, and C. Nanoff Kinetics of Ternary Complex Formation with Fusion Proteins Composed of the A1-Adenosine Receptor and G Protein alpha -Subunits J. Biol. Chem., October 22, 1999; 274(43): 30571 - 30579. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Chen, A. G. Gilman, and T. Kozasa A Candidate Target for G Protein Action in Brain J. Biol. Chem., September 17, 1999; 274(38): 26931 - 26938. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Oh and J. E. Schnitzer Immunoisolation of Caveolae with High Affinity Antibody Binding to the Oligomeric Caveolin Cage. TOWARD UNDERSTANDING THE BASIS OF PURIFICATION J. Biol. Chem., August 13, 1999; 274(33): 23144 - 23154. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamashita, R. Wada, T. Sasaki, C. Deng, U. Bierfreund, K. Sandhoff, and R. L. Proia A vital role for glycosphingolipid synthesis during development and differentiation PNAS, August 3, 1999; 96(16): 9142 - 9147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schwencke, M. Yamamoto, S. Okumura, Y. Toya, S.-J. Kim, and Y. Ishikawa Compartmentation of Cyclic Adenosine 3',5'-Monophosphate Signaling in Caveolae Mol. Endocrinol., July 1, 1999; 13(7): 1061 - 1070. [Abstract] [Full Text] |
||||
![]() |
R.-V. Stan, L. Ghitescu, B. S. Jacobson, and G. E. Palade Isolation, Cloning, and Localization of Rat PV-1, a Novel Endothelial Caveolar Protein J. Cell Biol., June 14, 1999; 145(6): 1189 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rietveld, S. Neutz, K. Simons, and S. Eaton Association of Sterol- and Glycosylphosphatidylinositol-linked Proteins with Drosophila Raft Lipid Microdomains J. Biol. Chem., April 23, 1999; 274(17): 12049 - 12054. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Carman, M. P. Lisanti, and J. L. Benovic Regulation of G Protein-coupled Receptor Kinases by Caveolin J. Biol. Chem., March 26, 1999; 274(13): 8858 - 8864. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Galbiati, D. Volonte, D. Meani, G. Milligan, D. M. Lublin, M. P. Lisanti, and M. Parenti The Dually Acylated NH2-terminal Domain of Gi1alpha Is Sufficient to Target a Green Fluorescent Protein Reporter to Caveolin-enriched Plasma Membrane Domains. PALMITOYLATION OF CAVEOLIN-1 IS REQUIRED FOR THE RECOGNITION OF DUALLY ACYLATED G-PROTEIN alpha SUBUNITS IN VIVO J. Biol. Chem., February 26, 1999; 274(9): 5843 - 5850. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, J. A. Duncan, A. G. Gilman, and S. M. Mumby Persistent membrane association of activated and depalmitoylated G protein alpha subunits PNAS, January 19, 1999; 96(2): 412 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jakubik and T. Haga Effects of an Agonist, Allosteric Modulator, and Antagonist on Guanosine-gamma -[35S]thiotriphosphate Binding to Liposomes with Varying Muscarinic Receptor/Go Protein Stoichiometry Mol. Pharmacol., November 1, 1998; 54(5): 899 - 906. [Abstract] [Full Text] |
||||
![]() |
P. W. Shaul and R. G. W. Anderson Role of plasmalemmal caveolae in signal transduction Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L843 - L851. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kifor, R. Diaz, R. Butters, I. Kifor, and E. M. Brown The Calcium-sensing Receptor Is Localized in Caveolin-rich Plasma Membrane Domains of Bovine Parathyroid Cells J. Biol. Chem., August 21, 1998; 273(34): 21708 - 21713. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Waugh, D. Lawson, S. K. Tan, and J. J. Hsuan Phosphatidylinositol 4-Phosphate Synthesis in Immunoisolated Caveolae-like Vesicles and Low Buoyant Density Non-caveolar Membranes J. Biol. Chem., July 3, 1998; 273(27): 17115 - 17121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Wolf, M. G. Jobling, S. Wimer-Mackin, M. Ferguson-Maltzman, J. L. Madara, R. K. Holmes, and W. I. Lencer Ganglioside Structure Dictates Signal Transduction by Cholera Toxin and Association with Caveolae-like Membrane Domains in Polarized Epithelia J. Cell Biol., May 18, 1998; 141(4): 917 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Fagan, K. E. Smith, and D. M. F. Cooper Regulation of the Ca2+-inhibitable Adenylyl Cyclase Type VI by Capacitative Ca2+ Entry Requires Localization in Cholesterol-rich Domains J. Biol. Chem., August 18, 2000; 275(34): 26530 - 26537. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Baker, M. A. Booden, and J. E. Buss S-Nitrosocysteine Increases Palmitate Turnover on Ha-Ras in NIH 3T3 Cells J. Biol. Chem., July 14, 2000; 275(29): 22037 - 22047. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chen and D. R. Manning Regulation of Galpha i Palmitoylation by Activation of the 5-Hydroxytryptamine-1A Receptor J. Biol. Chem., July 28, 2000; 275(31): 23516 - 23522. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Rybin, X. Xu, M. P. Lisanti, and S. F. Steinberg Differential Targeting of beta -Adrenergic Receptor Subtypes and Adenylyl Cyclase to Cardiomyocyte Caveolae. A MECHANISM TO FUNCTIONALLY REGULATE THE cAMP SIGNALING PATHWAY J. Biol. Chem., December 22, 2000; 275(52): 41447 - 41457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Hughes, H. Zhang, D. E. Logothetis, and C. H. Berlot Visualization of a Functional Galpha q-Green Fluorescent Protein Fusion in Living Cells. ASSOCIATION WITH THE PLASMA MEMBRANE IS DISRUPTED BY MUTATIONAL ACTIVATION AND BY ELIMINATION OF PALMITOYLATION SITES, BUT NOT BY ACTIVATION MEDIATED BY RECEPTORS OR AlF4- J. Biol. Chem., February 2, 2001; 276(6): 4227 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Claas, C. S. Stipp, and M. E. Hemler Evaluation of Prototype Transmembrane 4 Superfamily Protein Complexes and Their Relation to Lipid Rafts J. Biol. Chem., March 9, 2001; 276(11): 7974 - 7984. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||